In Conversation With… Tonya Winders
"For more than 20 years, we've had monoclonal antibodies for asthma, yet only one in five eligible patients are on them. And in more than 80 countries, there isn’t a single biologic available." The ...
In Conversation With… Joyce Kullman
“Imagine how many lives could be saved if we spent as much energy on rare disease awareness and education as we do on celebrity culture.” Patient advocacy groups (PAGs) are critical in bridging the ...
In Conversation With… Kurtis Kaminishi, MD MBA
“A patient who already has PTSD is going to have a more sensitive nervous system that will be more reactive to the addition of an exogenous stressor such as steroids, creating a medication-based ...
In Conversation With… Lili Brillstein
“It is so important to educate payers and providers about the downstream adverse events and long-term costs associated with steroid use.” Lili Brillstein is an internationally recognized thought ...
In Conversation With… Noreen Henig, MD
“When used for long periods of time to treat chronic diseases, the accumulated steroid-toxicity can wreak havoc on a patient.” Noreen Henig, MD has built a distinguished career as a physician, ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
